Molina di Fiemme, Italy

Riccardo Catalano

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Molinda Di Fiemme, IT (2018)
  • Molina di Fiemme, IT (2020)

Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Riccardo Catalano: Innovator in Orodispersible Tablet Technology

Introduction

Riccardo Catalano is a notable inventor based in Molina di Fiemme, Italy. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of orodispersible tablets. With a total of 2 patents to his name, his work is recognized for its innovative approach to improving medication delivery.

Latest Patents

One of Riccardo Catalano's latest patents involves a granulate for the formulation of orodispersible tablets. This invention relates to a granulate comprising mannitol and sorbitol in a weight ratio of between 70:30 and 97:3. The patent also covers the use of this granulate in the preparation of orodispersible tablets, the tablets obtained from the granulate, and the production process for obtaining the granulate. This innovation aims to enhance the effectiveness and convenience of medication for patients.

Career Highlights

Riccardo Catalano is currently associated with E-Pharma Trento S.p.a., where he continues to develop and refine his inventions. His work at the company has positioned him as a key player in the pharmaceutical industry, focusing on innovative solutions that address patient needs.

Collaborations

Throughout his career, Riccardo has collaborated with talented individuals such as Massimiliano Rossi and Silvia Boschetti. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Riccardo Catalano's contributions to the field of pharmaceutical formulations, particularly in orodispersible tablets, highlight his innovative spirit and dedication to improving patient care. His patents and collaborations reflect a commitment to advancing technology in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…